Index
Measure ID Title
eMeasure ID Measure Type NQF ID High Priority
Submission Methods Risk Adjusted?
Registry Measure?
AAAAI2
Asthma: Assessment of Asthma Control – Ambulatory Care Setting
Process
Not Set True False
Not Set True False
Not Set True False
AAAAI5
Allergen Immunotherapy Treatment: Allergen Specific Immunoglobulin E (IgE) Sensitivity Assessed and Documented Prior to Treatment
Process
Not Set True False
Not Set True False
Not Set True False
AAAAI6
Documentation of Clinical Response to Allergen Immunotherapy within One Year
Process
Not Set True False
Not Set True False
Not Set True False
AAAAI8
Achievement of Projected Effective Dose of Standardized Allergens for Patient Treated With Allergen Immunotherapy for at Least One Year
Outcome
Not Set True False
Not Set True False
Not Set True False
AAAAI9
Assessment of Asthma Symptoms Prior to Administration of Allergen Immunotherapy Injection(s)
Process
Not Set True False
Not Set True False
Not Set True False
AAD1
Psoriasis: Assessment of Psoriasis Disease Activity
Process
Not Set True False
Not Set True False
Not Set True False
AAD2
Psoriasis: Screening for Psoriatic Arthritis
Process
Not Set True False
Not Set True False
Not Set True False
AAD3
Basal Cell Carcinoma/Squamous Cell Carcinoma: Mohs Surgery for Superficial Basal Cell Carcinoma of the Trunk for Immune Competent Patients
Process
Not Set True False
Not Set True False
Not Set True False
AAD4
Basal Cell Carcinoma/Squamous Cell Carcinoma: Mohs Surgery for Squamous Cell Carcinoma in Situ or Keratoacanthoma Type Squamous Cell Carcinoma 1 cm or Smaller on the Trunk
Process
Not Set True False
Not Set True False
Not Set True False
AAD5
Biopsy Reporting Time - Clinician to Patient
Process
Not Set True False
Not Set True False
Not Set True False
AAN1
Diabetes/Pre-Diabetes Screening for Patients with DSP
Process
Not Set True False
Not Set True False
Not Set True False
AAN10
Falls screening
Process
Not Set True False
Not Set True False
Not Set True False
Page 17 of 75
© 2025 - PremierOne Plus MIPS